Back to search

Medusa Pharmaceuticals Ltd

13261049

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

KINGSBURY HOUSE 468 CHURCH LANE, LONDON, NW9 8UA
Incorporated 11/03/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology
72190
Other research and experimental development on natural sciences and engineering

Officers

Dr James Steven Duboff

director · Since 11/03/2021

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 40

Also on 1 other board

Mr Peter John Courtenay Sarkies

director · Since 11/03/2021

UNIVERSITY LECTURER

BRITISH · ENGLAND · Age 40

Persons with Significant Control

Dr James Steven Duboff

25–50% shares
25–50% votes
Appoint directors

British · England · Age 40

Kingsbury House, 468 Church Lane, London, NW9 8UA

Notified 11/03/2021

Mr Peter John Courtenay Sarkies

25–50% shares
25–50% votes
Appoint directors

British · England · Age 40

Mrc, London Institute Of Medical Sciences, Du Cane Road, W12 0NN

Notified 11/03/2021

CompanyRankvs 1709+ SIC 72110 peers
47

Financial strength59th percentile among SIC peers · 15/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 0.05× · 2/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1709Medusa Pharmaceuticals Ltd
47
How is this score calculated?
Financial strength15/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/03/2025

Net Worth

£4k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£6k

Working capital

Current Assets

£317

Current Liabilities

£7k

Fixed Assets

£2k

2avg. employees

Balance Sheet

Assets less current liabilities£4k
Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
20250.05+£607
20240.49—
20230.86—

Derived from filed accounts. Not audited figures.